cardiovascular-agents and Hypertension--Malignant

cardiovascular-agents has been researched along with Hypertension--Malignant* in 8 studies

Reviews

2 review(s) available for cardiovascular-agents and Hypertension--Malignant

ArticleYear
[Hypertensive urgencies and emergencies].
    Hipertension y riesgo vascular, 2017, Volume: 34 Suppl 2

    Hypertensive urgencies and emergencies are common situations in clinical practice. Hypertensive urgencies are characterized by acute elevation of blood pressure without target organ damage. Hypertensive emergencies are life-threatening situations characterized by acute elevation of blood pressure and target organ damage. The aims of blood pressure control, antihypertensive drugs to use and route of administration will depend on the presence or absence of target organ damage and individual patient characteristics. The correct diagnosis and treatment of these situations are essential for patient prognosis. © 2017 SEHLELHA. Published by Elsevier España, S.L.U. All rights reserved.

    Topics: Acute Disease; Ambulatory Care; Antihypertensive Agents; Aortic Dissection; Cardiovascular Agents; Cardiovascular Diseases; Catecholamines; Emergencies; Hospitalization; Humans; Hypertension, Malignant; Hypertensive Encephalopathy; Stress, Psychological

2017
[Therapy of hypertensive crises].
    Medizinische Klinik (Munich, Germany : 1983), 2000, May-15, Volume: 95, Issue:5

    Hypertensive crisis is defined as an extreme elevation of arterial blood pressure, with diastolic pressure > 120 mm Hg, and represents an imminent risk to the patient. In such cases, a rapid orientating diagnosis and adequate antihypertensive treatment to avoid sequelae are needed, sometimes even before diagnostic tests are completed. Hypertensive emergencies and hypertensive urgencies can be distinguished. If the critical increase in blood pressure is associated with end-organ damage such as encephalopathy, acute left heart failure and pulmonary edema, angina pectoris, myocardial infarction or dissecting aortic aneurysm, a hypertensive emergency is present, that is an acute threat to the patient's life. A hypertensive emergency requires effective lowering of blood pressure within minutes, but not necessarily to normal range. The choice of suitable antihypertensive agents depends on clinical symptoms, contraindications, duration of pressure elevation and underlying conditions, prior cardiovascular, cerebrovascular and renal disorders. The risk of imminent end-organ damage must be weighed against the risk of rapid blood pressure lowering. In hypertensive urgencies without end-organ complications, blood pressure can be lowered more slowly over several hours, often with oral agents to avoid detrimental fall in blood pressure. The drugs of choice are mainly urapidil i.v. and nitroglycerine.

    Topics: Cardiovascular Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Emergency Treatment; Humans; Hypertension; Hypertension, Malignant; Time Factors; Vasodilator Agents

2000

Other Studies

6 other study(ies) available for cardiovascular-agents and Hypertension--Malignant

ArticleYear
Long-term combined drug therapy in non-malignant hypertension.
    Acta medica Scandinavica, 1958, Mar-17, Volume: 160, Issue:3

    Topics: Cardiovascular Agents; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Reserpine

1958
[Pentapyrrolidinium (ansolysen) therapy of malignant hypertension].
    Belgisch tijdschrift voor geneeskunde, 1955, Aug-01, Volume: 11, Issue:15

    Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Pentolinium Tartrate

1955
Methonium treatment of severe and malignant hypertension.
    Journal of chronic diseases, 1955, Volume: 1, Issue:5

    Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central

1955
Results of methonium treatment of hypertensive patients, based on 250 cases treated for periods up to 3 1/2 years including 28 with malignant hypertension.
    British medical journal, 1954, Mar-27, Volume: 1, Issue:4864

    Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central

1954
[Combines therapy of malignant hypertension].
    Wiener medizinische Wochenschrift (1946), 1954, May-15, Volume: 104, Issue:20-21

    Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Rauwolfia

1954
Hexamethonium and apresoline (L-hydrazinophthalazine) in the treatment of malignant hypertension; report of a case.
    Rhode Island medical journal, 1954, Volume: 37, Issue:10

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Sympatholytics

1954